This
report has been written to provide members of pharmaceutical,
biotechnology and clinical research sectors an analytically-based
overview of the mechanisms of the partnering process,
and the key issues and trends affecting these arrangements.
The modern pharmaceutical company faces numerous
challenges in its efforts to improve productivity
and to strengthen the product portfolio. In an attempt
to counteract the pressures of operating in a global
pharmaceutical market, companies have sought to
establish relationships with external partners such
as biotechnology companies and Clinical Research
Organizations (CROs) as a means to remaining competitive
and profitable. Alliances and external collaborations
have provided companies with the opportunity to
gain access to new technological breakthroughs and
novel expertise regardless of national or geographical
boundaries.
Evidence
of the growing emphasis on alliances and external
collaborations as a route to success is highlighted
by the fact that partnerships within the biopharmaceutical
sector are currently being formed at the rate of
$5 billion per year. This new report is designed
to provide information, insight and in-depth analysis
of alliance and licensing activity within the pharmaceutical
industry in order to identify the challenges faced
by members of the pharmaceutical community; current
trends in partnering activity; an understanding
of the dynamics of the buyer-supplier relationship
and best practices for managing external collaborations.
The
report is aimed at providing an appraisal of the
partnering process, and insights into the current
environment of pharmaceutical discovery and development.
Strategies
for Innovation in Pharmaceutical R&D includes the
following features:
-
A
thorough market analysis of the global pharmaceutical
industry, including the challenges faced by pharmaceutical
manufacturers and the technological developments
currently affecting innovation
-
A
review of key developments taking place in the
environment of pharmaceutical R&D and an evaluation
of possible strategies for facilitating the drug
discovery and development process
-
Analysis
of the significance of biotechnology to the pharmaceutical
industry, including key trends in pharmaceutical
alliance and licensing agreements
-
An
assessment of the importance of outsourcing to
the drug development process, and an overview
of the market for contract research, including
key trends in pharmaceutical licensing agreements
-
Guidelines
for partnership management, with profiles of market
leaders in the areas of pharmaceuticals, biotechnology
and clinical research
-
An
informative and vital source of reference that
provides practitioners with easy to access case
studies, tabular data, key competitor profiles
and a glossary of key pharmaceutical terms and
definitions, with details of alliance and licensing
deals within the biopharmaceutical sector
|
